BridgeMD
New treatment option for Shoulder Instability
Official title Surgical Treatment of Recurrent Shoulder Dislocations
ClinicalTrials.gov ID: NCT05564494
What this study is testing
- What it's testing
- This is a pilot multi-centre, double blinded randomized controlled trial. The primary outcome of this pilot trial will be feasibility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 40. Healthy volunteers may be eligible.
You may be able to join if
- Recurrent anterior glenohumeral dislocation (two or more incidents)
- Presence of glenoid and/or humerus bone loss on imaging (x Ray, CT or MRI)
You likely can't join if
- Uncontrolled diabetes (Hgb A1C \>7%)
- Prior surgery of affected shoulder
- Pregnancy
- Multidirectional instability
- Posterior instability
- Paralysis of the shoulder
See the full eligibility criteria
- Recurrent anterior glenohumeral dislocation (two or more incidents)
- Presence of glenoid and/or humerus bone loss on imaging (x Ray, CT or MRI)
- Uncontrolled diabetes (Hgb A1C \>7%)
- Prior surgery of affected shoulder
- Pregnancy
- Multidirectional instability
- Posterior instability
- Paralysis of the shoulder
- Cancer
- Severe systemic illness
- Presence of massive rotator cuff tear
- Patients that present with \ 25% bone loss under preoperative imaging.
- Generalized laxity (\>5/9 Beighton Score)
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States; Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.